Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.
Interview
Adapting to Tariffs and Strengthening Regional Networks
Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.
Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.
September 3 – 5, 2025 | Join hundreds of women throughout the chemical industry that will gather at Women in Chemicals Second Annual conference in Chicago, IL.
September 10 – 12, 2025 | The International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Diagnostics will have an offshoot in the USA for the first time in 2025. Analytica USA will take place at the Greater Columbus Convention Center.
September 10 – 12, 2025 | The European Association of Chemical Distributors invites you to embark on a 3-day journey, encompassing unique insights from major value-chain players in combination with lots of facts & figures, ample networking opportunities plus entertainment.
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.
